Bernie Sanders set to influence FDA funding bill negotiations
Sen. Bernie Sanders is expected to lead Senate health committee discussions on renewing the Prescription User Fee Drug Act before its Sept. 30 expiration.
Senate leadership shifts power dynamics
Democrats won a landslide victory in the midterm elections. This outcome gives senior lawmakers significant influence over upcoming negotiations. Sen. Bernie Sanders will likely lead the Senate health committee.
Opposition to user fee structure grows
Sanders opposes the core premise of the current user fee system. The FDA collects these fees from pharmaceutical companies to fund medicine reviews. Disruption could occur if the act is not renewed by Sept. 30.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.